CAITLYN MCBRIDE: Open Payments
NPI 1316602006 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 25 payments from 11 companies in 2025. Trend: 2023 $534 · 2024 $538 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $193 |
| Teva Pharmaceuticals USA, Inc. | 2 | $135 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| PFIZER INC. | 3 | $74 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| Novo Nordisk Inc | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Seqirus USA Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: AUSTEDO XR, ZEPBOUND, MOUNJARO, PREVNAR 20, JARDIANCE, AIRSUPRA, CAPVAXIVE, Rybelsus.
Industry payments across PA — which companies pay providers there.
